Current location:Culture Capsule news portal > politics
Why Amylyx is pulling ALS drug Relyvrio from US market after study
Culture Capsule news portal2024-05-22 02:27:31【politics】9People have gathered around
IntroductionWASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study
WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it will pull the medicine from the market, acknowledging it didn’t help patients with the deadly neurological condition.
Amylyx Pharmaceuticals announced it will voluntarily halt sales and marketing of the drug in the U.S. and Canada, where new patients will no longer be able to get a prescription.
“While this is a difficult moment for the ALS community, we reached this path forward in partnership with the stakeholders who will be impacted and in line with our steadfast commitment to people living with ALS,” company co-founders said in a statement. Patients already taking the therapy who wish to continue will be able to enroll in a program to receive it for free.
The Food and Drug Administration approved the much-debated drug, Relyvrio, in September 2022, following a years-long advocacy campaign by patients with amyotrophic lateral sclerosis, or ALS.
Address of this article:http://samoa.highlanderdistrict.org/article-69e099831.html
Very good!(2471)
Related articles
- Abbey Clancy, 38, shows off a new set of train track braces as she's left red
- Trump seeks Supreme Court pause in 2020 election case
- Chinese court sentences Australian Yang Hengjun to death with two
- The engineer designing needles to euthanise whales
- Why US Catholics are planning pilgrimages in communities across the nation
- Christchurch man jailed for 14 years over role in US porn videos
- NASA's historic Mars helicopter Ingenuity grounded for good after 72 flights
- Spirit down Dash 3
- Shohei Ohtani's first walk
- Some imported animal products using production methods illegal in New Zealand
Popular articles
Recommended
Sports betting roundup: Xander Schauffele's final putt pays off for bettors
Chinese court sentences Australian Yang Hengjun to death with two
Live updates: Hurricanes v Chiefs, Super Rugby Pacific round 8
What we're watching: The Great
Mohammad Mokhber: Who is Iran’s acting president?
Nelson urgently needs revitalisation as economic performance slumps
Some imported animal products using production methods illegal in New Zealand
Swedish alarm after defence chiefs' war warning
Links
- China calls for strengthened flood control in Yangtze, Taihu Lake basins
- China discloses tasks of Shenzhou
- Xi inspects southwest China's Chongqing Municipality
- Gunnar Henderson's leadoff homer launches big 1st inning for Orioles in 9
- Recovering China outbound, inbound travel boosting global tourism market
- China compiles inventory of 914,000 patents: CNIPA
- Jon Rahm's cut streak at majors ends at 18 following two so
- King Charles and Queen Camilla could miss super
- Houston windstorms: Once
- José Ramírez's homer in 8th inning leads Guardians to 3